Objective: Cystic ameloblastoma, keratocystic odontogenic tumor, dentigerous cyst, and radicular cyst are the most commonly encountered cystic odontogenic lesions. The aim of this study was to investigate the expressions of survivin, E-cadherin, CD138, and CD38 in these lesions and their potential diagnostic usage.
InTRODUCTIOn
Cystic ameloblastoma (CA), keratocystic odontogenic tumor (KCOT), dentigerous cyst (DC), and radicular cyst (RC) are the most commonly encountered cystic odontogenic lesions. Among cystic odontogenic lesions, ameloblastoma and keratocystic odontogenic tumors (KCOTs) are regarded as benign, but they can be locally invasive with extensive bone destruction.
Survivin, which is an inhibitor of apoptosis protein (IAP), is a bifunctional protein that suppresses apoptosis by inhibiting caspase activation while regulating cell division and promoting cell proliferation, differentiation, and angiogenesis at the same time (1) . Survivin is expressed in many various human malignancies including hepatocellular carcinoma, colorectal cancer, lung cancer, pancreatic and kidney cancers, and osteosarcoma (2) (3) (4) (5) (6) (7) . Survivin plays an important role both in initiation and progression of these tumors (2) (3) (4) (5) (6) (7) . Over-expression of survivin is suggested to be associated with aggressive behavior in KCOTs and ameloblastomas (8, 9) . E-cadherin is the major Ca 2+ dependent cell adhesion molecule of epithelial cells and plays a role in morphogenesis and the maintenance of the integrity of epithelial cells (10, 11) . E-cadherin expression is inversely proportional to the degree of differentiation in various cancers. Loss of E-cadherin-mediated cell-cell adhesion is associated with the progression of many carcinomas including breast, bladder, gastric, squamous head and neck cancers (12) (13) (14) (15) . Loss of E-cadherin expression in the epithelium of invasive squamous cell carcinomas and squamous intraepithelial lesions of the uterine cervix and skin reduces the density of Langerhans cells, and thus compromises the capacity of dendritic cells to recognize tumor antigens (16) (17) (18) . CD138 and CD38 have been widely used as plasma cells markers in hematopoetic malignancies (19, 20) . CD138, also known as syndecan 1, is a transmembrane heparin sulfate proteoglycan. CD138 (syndecan 1 is a highly expressed antigen in epithelial cells. However, expressions of other syndecans, syndecan 2 in mesothelial, endothelial, neural and fibroblastic cells, syndecan 3 in neural cells, and syndecan 4 in epithelial and fibroblastic cells, are known not to be high in epithelial cells. CD138 (syndecan 1) is a receptor for extracellular matrix proteins such as collagen, fibronectin and thrombospondin, and participates in cell proliferation, cell migration, and cell interactions (19, 20) . CD138 plays a role in the differentiation of B lymphocytes to plasma cells and is observed in non-neoplastic plasma cells, neoplastic plasma cells in multiple myeloma, and the plasmacytic component in lymphoplasmacytic lymphoma (20) . It is also expressed in many solid tumors including breast, colon, lung, prostate, and kidney cancers (20) (21) (22) (23) . It modulates cancer cell proliferation and apoptosis, angiogenesis, tumor invasion, and metastasis (21) . Loss of CD138 expression is associated with increased invasive and metastatic potential in carcinomas (22) . It has been suggested that CD138 is essential for the maintenance of epithelial morphology and control of cytoskeletal organization and its expression has prognostic value in clinical outcome of ameloblastomas and odontogenic cysts (24) .
CD38 is a transmembrane molecule and found on the surface of many immune cells including CD4+, CD8+, and B lymphocytes, in addition to natural killer cells. CD38 also functions in cell adhesion, signal transduction and calciumdependent cell signaling pathways (25, 26) .
The differential diagnosis in odontogenic cystic lesions and the understanding of their pathogenesis are essential for their accurate diagnosis and the determination of appropriate treatment modalities. Although there are several studies related to role of these proteins in odontogenic lesions in English literature (8, 9, 18, 24, (27) (28) (29) , no comparative and comprehensive study, in which the expression of these proteins or adhesion molecules in odontogenic cystic lesions have been evaluated, to our knowledge. Therefore, we aim to evaluate the immunohistochemical expressions of CD138 (syndecan-1), CD38, E-cadherin and survivin in these cystic odontogenic lesions and investigate the potential implications of their expressions among these lesions.
MATERIAL and METHODS
A total of 20 cases consisting 5 radicular cysts (RCs), 5 dentigerous cysts (DCs), 5 keratocystic odontogenic tumors (KCOTs) and 5 cystic ameloblastomas (CAs) were included in this study. For all cases, sections from the selected blocks were stained against the antibodies for survivin (Neomarkers, Labvision, Ab-2, clone 4F7, 1/100 dilution, avidin-biotin-peroxidase), E-cadherin (Dako, Clone NCH-38, 1/100 dilution, avidin-biotin-peroxidase), CD138 (Cell Marqoue, clone B-A38, 1/100 dilution, avidinbiotin-peroxidase), and CD38 (Novocastra, clone NCL-CD38-290, 1/100 dilution, avidin-biotin-peroxidase) on an automated device (Ventana, Benchmark XT). The staining intensity was graded and recorded semi-quantitatively as 0 (no staining), 1+ (weak), 2+ (moderate) and 3+ (strong).
RESULTS
All staining scores were summarized in Table I .
The features of survivin expression in the cystic odontogenic lesions: All CAs (Figure 1 A,B) and KCOTs (Figure 1 C,D) showed diffuse and strong nuclear survivin expression in all epithelial and stromal cells with some weak cytoplasmic staining, as well. Epithelial staining in these cases was strongest in basal cell layer. In contrast, weak cytoplasmic and nuclear staining in all epithelial layers with basal cell Membranous CD138 expression with basal cell accentuation was seen in all epithelial layers of CAs, DCs and RCs, whereas it was only detected in basal and suprabasal cells of KCOTs. CD 38 was negative in all cases.
DISCUSSIOn
Dentigerous cyst (DC) and radicular cyst (RC) are nonneoplastic odontogenic lesions, whereas cystic ameloblastoma (CA) and keratocystic odontogenic tumors (KCOTs) are benign neoplastic odontogenic lesions and they may become locally invasive lesions with extensive bone destruction.
Recently, some studies demonstrated that over-expression of survivin is associated with the more aggressive and invasive phenotype of oral squamous cell carcinoma (30, 31 (9) . They also documented that there was no or only weak survivin staining in radicular or apical cysts. Our results were concordant with the results of both studies. However, there was no information regarding survivin expression in stromal cells in them. Presented study also revealed that strong cytoplasmic and nuclear survivin staining in stromal cells was in CAs and KCOTs, but weak staining in DCs and RCs. In the article of de Oliveira et al. (27) , survivin staining patterns in DCs and KCOTs is also similar to our observations. Furthermore, some authors hypothesized that cytoplasmic survivin expression is responsible for poor prognosis and for the resistance to therapy in oral squamous cell carcinoma (31) . Although effects of nuclear vs. cytoplasmic expression of survivin are still ambiguous, some investigators have reported that predominantly nuclear survivin over-expression is a negative prognostic factor in oropharyngeal squamous cell carcinomas (32) . We observed both nuclear and cytoplasmic survivin expression in all cases in varying proportion. compromises the capacity of dendritic cells to recognize tumor antigens (16) (17) (18) . Our study revealed that E-cadherin expression was stronger in non-neoplastic odontogenic cysts (DCs and RCs) rather than neoplastic odontogenic cysts (CAs and KCOTs). These findings support this theory and are similar to the data of previous studies.
Some authors suggested that loss of E-cadherin expression in neoplastic odontogenic cysts such as CAs and KCOTs reduces the density of Langerhans cells and thus
Some authors reported that loss of CD138 (syndecan 1) expression in epithelial cells is associated with increased invasive and metastatic potential in some cancers (22, 28) . Recently, Bologno-Malina et al. demonstrated that solid/ multicystic ameloblastomas had more aggressive biological behavior than the unicystic ameloblastomas (28) . In our series, all ameloblastomas were unicystic. In the study of Nadalin et al. (29) , CD138 expression was detected in all epithelial layers of KCOTs, RCs and DCs. Our results were similar to the findings of previous studies, but we also observed CD138 expression in the stromal cells. CD138 is normally expressed in the epithelial cells and some mesenchymal cells such as plasma cells and immature B lymphocytes. However, it has been demonstrated that CD138 is expressed by the stromal cells in the some neoplastic and non-neoplastic odontogenic lesions (ameloblastoma, KCOT and DC), and ovarian cancers, as well as plasma cells (24, 33) . It has also been stated that the expression of CD138 is associated with poor prognosis (24, 33) . CD138 (syndecan 1) shifting from epithelium to stroma was reported in invasive non-odontogenic solid tumors including breast, prostate, lung, and colon cancers (21) . Al-Otaibi et al. showed that CD138 expression was 4-CD38 is negative in all cases and is not a useful marker in cystic odontogenic lesions.
An immunohistochemical panel consisting of survivin, E-cadherin, and CD138 excluding CD38 antibody may be useful in the diagnosis of cystic odontogenic lesions. These findings are also reinforced by the studies suggesting their role in the aggressiveness and pathogenesis of these tumors. present in the stromal cells of ameloblastoma, KCOT and DC (24) . A role of CD138 expression in the stromal cells and extracellular matrix can be hypothesized as a critical factor for tumorigenesis and local invasiveness of ameloblastomas (24) . We also observed CD138 expression in the stromal cell in all cases, especially pronounced in CAs.
Although CD38 has a wider spectrum of B-cell staining than does CD138, there is no expression in neoplastic or non-neoplastic epithelial cells like CD138.
To summarize;
1-A weak E-cadherin expression in epithelial cells, strong CD138 expression in stromal cells, and strong nuclear survivin expressions both in epithelial and stromal cells are characteristic features for CAs and KCOTs. 
